What is Solution21?
Solution21, also known as Radiation Oncology Specialists of Central Virginia, is a healthcare provider specializing in advanced cancer diagnosis and treatment. The company offers cutting-edge services such as Stereotactic Body Radiation Therapy and Prostate Brachytherapy, aiming to enhance the quality of life for cancer patients through clinically proven, non-invasive methods. Operating from two locations in central Virginia, Solution21's board-certified physicians leverage state-of-the-art technology to deliver personalized patient care. Their core mission revolves around providing hope and comprehensive support throughout a patient's cancer treatment journey.
How much funding has Solution21 raised?
Solution21 has raised a total of $92K across 1 funding round:
Debt
$92K
Debt (2021): $92K with participation from PPP
Key Investors in Solution21
PPP
Public-Private Partnership
What's next for Solution21?
With the recent influx of substantial expansion capital, Solution21 is poised for significant strategic advancements. This funding is expected to fuel further development of their advanced radiation oncology services, potentially enabling geographic expansion, enhancement of technological capabilities, and scaling of operational infrastructure. The company's progression through Series B/C stages suggests a focus on solidifying market leadership and increasing patient access to their specialized cancer treatments. Future initiatives will likely concentrate on optimizing treatment delivery, expanding service offerings, and reinforcing their commitment to improving patient outcomes in oncology.
See full Solution21 company page
